Intervention for Medical Student to Promote Cervical Cancer Screening Among Latinx Transmasculine Individuals
NCT ID: NCT06844097
Last Updated: 2025-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
60 participants
INTERVENTIONAL
2025-04-07
2026-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
HPV Self-Sampling for Cervical Cancer Screening Among Transgender Men and Transmasculine Individuals
NCT03222817
Implementing HPV DNA Self-Collection to Increase Rates of Cervical Cancer Screening in Transgender Men
NCT04154358
Effectiveness of an EHealth Intervention for Uptake of Cervical Cancer Screening in Hispanic Women
NCT06741241
Uniting Trusted Community Messengers to Improve Access to Cervical Cancer Screening in Rural North Carolina
NCT07294066
The Effectiveness, Cost-effectiveness, and Budget Impact of Interventions to Improve the Delivery of Cervical Cancer Screening in Puerto Rico.
NCT06943547
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The proposed study aims to: 1) Test the effectiveness of the intervention in increasing medical students' knowledge, attitudes, and skills for providing healthcare to LTM-NB. , 2) Determine the acceptability, appropriateness, and feasibility of implementing the interventions in real-world medical educational settings.
While the team has preliminary data regarding the efficacy of the intervention, this pilot is proposing a rigorous study design: Aim 1 will measure the magnitude of effect of the intervention, and Aim 2 measures the implementation. This study will address cervical cancer disparities among LTM-NB individuals. The impact of this study will reveal new effective interventions and implementation strategies. The translational implications of this work will result in providing medical schools with a cross-cultural tool to train students on cervical cancer prevention for LTM-NB individuals.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cervical Cancer Trans Inclusive Education (CC-TRAINED) Module
Participants assigned to the experimental condition will receive the CC-TRAINED intervention.
Cervical Cancer Trans Inclusive Education (CC-TRAINED) Module
An online course designed to increase cervical cancer prevention clinical skills among medical students when working with Latinx transmasculine populations.
Disaster Preparedness Course
Participants randomized to the control condition will receive a Disaster Preparedness Course, addressing the basics of natural disaster preparedness
Disaster Preparedness Course
An online course designed to improve professionals' skills and competencies for engaging in disaster preparedness.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cervical Cancer Trans Inclusive Education (CC-TRAINED) Module
An online course designed to increase cervical cancer prevention clinical skills among medical students when working with Latinx transmasculine populations.
Disaster Preparedness Course
An online course designed to improve professionals' skills and competencies for engaging in disaster preparedness.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
H. Lee Moffitt Cancer Center and Research Institute
OTHER
Ponce Medical School Foundation, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alixida Ramos Pibernus, PhD
Role: PRINCIPAL_INVESTIGATOR
Ponce Health Sciences University
Matthew B Schabath, PhD
Role: PRINCIPAL_INVESTIGATOR
H. Lee Moffit Cancer Center and Research Institute
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2308159535R001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.